Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine versus hyoscine for prevention of oculocardiac reflex during scleral buckling surgery
IRCT20120307009229N6Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atropine and scopolamine in oculocardiac reflex (OCR) (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Vital signs over time during surgery and Frequency of oculocardiac reflex. Started May 2019; status: completed.
02
Drugs
atropinescopolamine
03
Conditions
oculocardiac reflex (OCR)
Beyond the preview
Go deeper on IRCT20120307009229N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120307009229N6.